The prolongation of the survival times of mice implanted with TLX5 cells by treatment with methotrexate encapsulated in erythrocytes.
D000818:Animals; D004912:Erythrocytes; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*
D008727:Methotrexate